Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1365743rdf:typepubmed:Citationlld:pubmed
pubmed-article:1365743lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:1365743lifeskim:mentionsumls-concept:C0020616lld:lifeskim
pubmed-article:1365743lifeskim:mentionsumls-concept:C0034428lld:lifeskim
pubmed-article:1365743lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:1365743lifeskim:mentionsumls-concept:C0359086lld:lifeskim
pubmed-article:1365743lifeskim:mentionsumls-concept:C0205464lld:lifeskim
pubmed-article:1365743lifeskim:mentionsumls-concept:C0681814lld:lifeskim
pubmed-article:1365743pubmed:issue1-3lld:pubmed
pubmed-article:1365743pubmed:dateCreated1995-3-9lld:pubmed
pubmed-article:1365743pubmed:abstractTextThe association between antibiotics and oral hypoglycemic agents can determine various pharmacological interactions. The aim of our work has been to verify experimentally the eventual pharmacological interactions that may occur when some quinolones (nalidixic acid, ofloxacin, pefloxacin and sparfloxacin) are administered in association with oral hypoglycemic drugs (phenphormine and glibenclamide). Our results showed that ofloxacin, pefloxacin and sparfloxacin only at high dosages (not used in the human clinic) can increase the phenphormine and glibenclamide hypoglycemic effect. The nalidixic acid, just at therapeutic doses, is able to increase the hypoglycemic effect of the drugs studied.lld:pubmed
pubmed-article:1365743pubmed:languageitalld:pubmed
pubmed-article:1365743pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1365743pubmed:citationSubsetIMlld:pubmed
pubmed-article:1365743pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1365743pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1365743pubmed:statusMEDLINElld:pubmed
pubmed-article:1365743pubmed:issn0017-0445lld:pubmed
pubmed-article:1365743pubmed:authorpubmed-author:RossiFFlld:pubmed
pubmed-article:1365743pubmed:authorpubmed-author:VaccaCClld:pubmed
pubmed-article:1365743pubmed:authorpubmed-author:AngrisaniMMlld:pubmed
pubmed-article:1365743pubmed:authorpubmed-author:LosassoCClld:pubmed
pubmed-article:1365743pubmed:authorpubmed-author:LoffredaAAlld:pubmed
pubmed-article:1365743pubmed:authorpubmed-author:MarabeseIIlld:pubmed
pubmed-article:1365743pubmed:issnTypePrintlld:pubmed
pubmed-article:1365743pubmed:volume39lld:pubmed
pubmed-article:1365743pubmed:ownerNLMlld:pubmed
pubmed-article:1365743pubmed:authorsCompleteYlld:pubmed
pubmed-article:1365743pubmed:pagination1-4lld:pubmed
pubmed-article:1365743pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1365743pubmed:meshHeadingpubmed-meshheading:1365743-...lld:pubmed
pubmed-article:1365743pubmed:meshHeadingpubmed-meshheading:1365743-...lld:pubmed
pubmed-article:1365743pubmed:meshHeadingpubmed-meshheading:1365743-...lld:pubmed
pubmed-article:1365743pubmed:meshHeadingpubmed-meshheading:1365743-...lld:pubmed
pubmed-article:1365743pubmed:meshHeadingpubmed-meshheading:1365743-...lld:pubmed
pubmed-article:1365743pubmed:meshHeadingpubmed-meshheading:1365743-...lld:pubmed
pubmed-article:1365743pubmed:meshHeadingpubmed-meshheading:1365743-...lld:pubmed
pubmed-article:1365743pubmed:articleTitle[Pharmacologic interactions between quinolones and oral hypoglycemic agents. An experimental study on rabbits].lld:pubmed
pubmed-article:1365743pubmed:affiliationIstituto di Farmacologia e Tossicologia, Facoltà di Medicina e Chirurgia, Il Università degli Studi di Napoli.lld:pubmed
pubmed-article:1365743pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1365743pubmed:publicationTypeEnglish Abstractlld:pubmed